Implantation devices including hydrogel filaments

US10194915B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10194915-B2
Application numberUS-201615272305-A
CountryUS
Kind codeB2
Filing dateSep 21, 2016
Priority dateDec 21, 2007
Publication dateFeb 5, 2019
Grant dateFeb 5, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described are devices for implantation comprising a hydrogel filament wherein the hydrogel filament includes a low molecular weight ethylenically unsaturated macromer, an ethylenically unsaturated monomer, and a visualization agent. Methods of making and using these devices are also described.

First claim

Opening claim text (preview).

We claim: 1. A device for implantation comprising: a hydrogel filament attached to a coupler wherein the coupler is attached to a pusher, wherein the hydrogel filament includes a low molecular weight ethylenically unsaturated macromer; an ethylenically unsaturated monomer; and visualization agent having a structure of 2,4,6-triiodophenyl penta-4-enoate, wherein said device contains no support members. 2. The device of claim 1 , wherein said macromer has a molecular weight of about 100 grams/mole to about 5000 grams/mole. 3. The device of claim 1 , wherein said macromer comprises polyethylene glycol, propylene glycol, poly(tetramethylene oxide), poly(ethylene glycol) diacrylamide, poly(ethylene glycol) diacrylate, poly(ethylene glycol) di methacrylate, derivatives thereof, or combinations thereof. 4. The device of claim 1 , wherein said macromer and said monomer are crosslinked with N,N,N′,N′-tetramethylethylenediamine, ammonium persulfate, azobisisobutyronitrile, benzoyl peroxides, 2,2′-azobis(2-methylpropionamidine) dihydrochloride, derivatives thereof, or combinations thereof. 5. The device of claim 1 , wherein said hydrogel is substantially free of acrylamide. 6. The device of claim 1 , wherein said hydrogel is substantially non-bioresorbable. 7. The device of claim 1 , wherein said visualization agent is at a concentration of about 40% w/w to about 80% w/w of a prepolymer solution used to form the hydrogel filament. 8. A device for implantation comprising: an introducer loaded with a hydrogel filament, wherein the introducer attaches to a catheter or microcatheter, wherein the hydrogel filament includes a low molecular weight ethylenically unsaturated macromer; an ethylenically unsaturated monomer; and visualization agent having a structure of 2,4,6-triiodophenyl penta-4-enoate, wherein said device contains no support members. 9. The device of claim 8 , wherein said macromer has a molecular weight of about 100 grams/mole to about 5000 grams/mole. 10. The device of claim 8 , wherein said macromer comprises polyethylene glycol, propylene glycol, poly(tetramethylene oxide), poly(ethylene glycol) diacrylamide, poly(ethylene glycol) diacrylate, poly(ethylene glycol) di methacrylate, derivatives thereof, or combinations thereof. 11. The device of claim 8 , wherein said macromer and said monomer are crosslinked with N,N,N′,N′-tetramethylethylenediamine, ammonium persulfate, azobisisobutyronitrile, benzoyl peroxides, 2,2′-azobis(2-methylpropionamidine) dihydrochloride, derivatives thereof, or combinations thereof. 12. The device of claim 8 , wherein said hydrogel is substantially free of acrylamide. 13. The device of claim 8 , wherein said hydrogel is substantially non-bioresorbable. 14. The device of claim 8 , wherein said visualization agent is at a concentration of about 40% w/w to about 80% w/w of a prepolymer solution used to form the hydrogel filament.

Assignees

Inventors

Classifications

  • (bio)absorbable, (bio)resorbable or resorptive · CPC title

  • obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)} · CPC title

  • Porous materials, {e.g. foams or sponges} · CPC title

  • containing barium sulfate · CPC title

  • Use of materials characterised by their function or physical properties · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10194915B2 cover?
Described are devices for implantation comprising a hydrogel filament wherein the hydrogel filament includes a low molecular weight ethylenically unsaturated macromer, an ethylenically unsaturated monomer, and a visualization agent. Methods of making and using these devices are also described.
Who is the assignee on this patent?
Microvention Inc
What technology area does this patent fall under?
Primary CPC classification A61L27/16. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).